Daily news email for February 13, 2012 | Click here for updated news

SourceSolution News
We want to hear from you! Click here let us know how we can make this news email better.

Manage projects more efficiently. Try PlanIt free for 15 days.

Create quality questionnaires and RFPs more quickly, weight responses and manage suppliers.

Discounted advertising rates on www.sourcesolution.com for all BIOCOM members starting at $100/month

Use PlanIt as your next deal room! Click here to learn more.

b3c newswire
Vectron Biosolutions Obtains Strong Results for Biosimilar Production

Sistemic to Work with TiGenix On Landmark EUR 5. ...

Xceleron Announces New Investment and Move to Purpose-Built Laboratories in U.S.

IDEA Bio-Medical Sells HTS/HCS Cell Imaging System to The Medical University of South Carolina

Biotage Introduces Biotage® SNAP Ultra High Performance Flash Chromatography Cartridges

BioSpace
With No Firm Science, Sleep Standards are Slipping, University of South Australia Study

AmerisourceBergen Corporation CFO Resigns

Bayer HealthCare Pharmaceuticals Files Suit Against Watson Pharmaceuticals, Inc. Over Birth Control Pill Patent

Tecan Appoints New Chief Executive Officer

GlaxoSmithKline to Study Traditional Chinese Medicine

BioSpace - Breaking News
Trevena, Inc. Initiates Clinical Development of TRV130, a Biased Mu-Opioid Ligand for Severe Post-Operative Pain

Titan Pharmaceuticals Commences Phase 2 Clinical Study of Anti-Angiogenic Treatment for Pancreatic Cancer

Dynavax Technologies Corporation Release: Phase 3 Data on HEPLISAV(TM) in Adults Aged 18-55 Published in

Watson Pharmaceuticals, Inc. Confirms Beyaz(R) Patent Challenge

Horizon Pharma, Inc. Modifies DUEXIS(R) Marketing Authorization Application to Include Recently Approved Manufacturing Site

Biotech News - Business Wire
Oxford Immunotec Announces Appointment of Richard Alteri as Chief Financial Officer

OvaScience to Present at the Leerink Swann 2012 Global Healthcare Conference

BSD Medical Appoints Thomas Sobba as U.S. National Sales Manager for MicroThermX® Line of Products

Medtronic Launches Two New Clinical Programs to Evaluate the Use of Symplicity1 Renal Denervation System across Multiple Conditions

OncoPep Enters Exclusive License Agreement with Dana-Farber for Novel Therapeutic Multi-Peptide Vaccine Technology for Hematologic Cancers

Biotech News - PR Newswire
TPI Begins Construction of Qionglai Facility (QLF)

Unilife to Present at the 2012 Leerink Swann Conference in New York City on February 15th

White Paper Details New Medical Device Polymer Biocompatibility Screening Test Using Zebrafish Embryos

VirtualScopics Schedules Fourth Quarter and Full Year 2011 Earnings Announcement

Allon's Data Safety Monitoring Board recommends continuation of pivotal clinical trial

Biotechnology - Moreover
Analysis of Relative Performance in the Biotechnology Industry for Shares of Incyte (INCY, ONXX, ALKS, SPPI, MITI)

Top 5 Companies in the Biotechnology Industry with the Best Relative Performance (CPHD, IMGN, HGSI, SGEN, RIGL)

NIH Translational Center Should Raise All Boats, BIO Says

Immunogen, inc. reports second quarter fiscal year 2012 financial results and provides quarterly update

Biotechnology to be 21st-century industry: Life Tech CEO

Burrill Report
The Sinews of Safety

Obama Administration Boosts Alzheimer's Research Spending

FDA Unveils Biosimilars Guidance

Medical Device Firms Bring In the Bucks

Siemens Seeks Growth in Companion Diagnostics

CenterWatch - Clinical Trials
Sanofi's $20 billion Genzyme buy could fuel a big pharma-biotechnology acquisition trend

New Quintiles initiative saves investigative sites the time, and cost, of patient recruitment advertising

Technology companies adapt interactive video concepts for clinical trial informed consent

CRI buys Lifetree, combining investigative sites on both coasts and across all trial phases

New $1b NIH center will tackle early-stage drug development to ease industry risk of failure

Clinical Trials - Business Wire
Banner Health Receives National Award for Excellence in Delivering High Quality, Cost-Effective Care

Foundation Medicine and Dana-Farber Cancer Institute Identify Novel Genomic Alterations in Lung and Colorectal Cancer

NTRR's Next New Supplement Tackles Erectile Dysfunction

OptiNose Announces First Patient Enrolled in Phase III Study of Sumatriptan Powder Delivered Intranasally with Innovative Bi-directional Device

bluebird bio to Present at the Leerink Swann 2012 Global Healthcare Conference

Clinical Trials - PR Newswire
Oxitec Secures £8 Million Investment to Continue Fight Against Dengue Fever

Verinata Health Announces Presentation and Publication of Top-Line Clinical Validation Study Results for its verifi Non-Invasive Prenatal Test

USANA® Probiotic Receives ConsumerLab.com Certification

First Prospective Clinical Trial of Adaptive Radiotherapy for Head & Neck Cancer Patients

University Teams Tap Mobile Phones and Social Networks to Fight Non-communicable Diseases

CNN Top Stories
Judge: Sandusky can see grandkids

Murdoch faces U.S. heat on hacking

Israel blames Iran for explosives

Cantor: U.S. should get tough on Iran

Greece in flames over budget cuts

Contract Pharma
Carbogen Amcis Completes Successful FDA Audit

Premier Research Names Marketing VP

Cobra Biologics Expands Team

Quintiles Launches New Capabilities in Asia

Particle Sciences, CHEMO in Hormone Development Pact

FDA Drugs- What's New
Comunicado de la FDA sobre la seguridad de los medicamentos: Nuevo factor de riesgo para la leucoencefalopatía multifocal progresiva (PML por sus siglas en inglés) relacionado con Tysabri (natalizumab)

Comunicado de la FDA sobre la seguridad de los medicamentos: Nuevo factor de riesgo para la leucoencefalopatía multifocal progresiva (PML por sus siglas en inglés) relacionado con Tysabri (natalizumab)

FDA Drug Safety Communication: Important drug interactions between Victrelis (boceprevir) and ritonavir-boosted human immunodeficiency virus (HIV) protease inhibitor drugs

FDA Drug Safety Communication: Clostridium difficile-associated diarrhea can be associated with stomach acid drugs known as proton pump inhibitors (PPIs)

Prescription to Over-the-Counter (OTC) Switch List

FDA News - Business Wire
Samenvatting: Diffusion Pharmaceuticals start klinisch onderzoek van TSC; een nieuw medicijn tegen hersenkanker

FDA Approves ZIOPTAN (tafluprost ophthalmic solution), Merck's Once-Daily, Preservative-Free Ophthalmic Medication

Diffusion Pharmaceuticals Begins Clinical Trial of TSC, a New Drug for Treatment of Primary Brain Cancer

Riassunto: Diffusion Pharmaceuticals inizia la sperimentazione clinica per il TSC, un nuovo farmaco per il trattamento del cancro al cervello primario

Diffusion Pharmaceuticals Comienza Ensayo Clínico con TSC, un Nuevo Fármaco para el Tratamiento de Cáncer Cerebral Primario

FDA Press Releases
New Jersey company agrees to halt production of unapproved dental devices

FDA investigating illegal online sale of handheld dental X-ray units

FDA issues draft guidance on biosimilar product development

FDA and industry reach agreement in principle on medical device user fees

FDA approves Gleevec for expanded use in patients with rare gastrointestinal cancer

FDA Vaccines, Blood and Biologics - What's New
Cord Blood Banking Information for Consumers

Cord Blood Banking – Information for Consumers

Cord Blood Banking ââ¬â Information for Consumers

Influenza Virus Vaccine for the 2011 - 2012 Season

Fluzone, Fluzone High-Dose and Fluzone Intradermal

FierceBiotech
Preclinical study triggers 'massive response' from desperate Alzheimer's patients

Hungry Valeant snags Eyetech in ongoing buyout spree

U.K. charities campaign to modify pricey regs in trials directive

NeurogesX slammed again as FDA panel spurns pain patch

Eisai loses panel vote on new Dacogen use

FierceBiotech IT
Belgian researchers access CLC bio's sequence analysis software

BioClinica sheds light on 2012 outlook, eyes ePRO tech for trials

German drug data outfit slammed for potential privacy breach

Dutch researchers access CLC bio's sequence analysis software

CRO ESTERN, Nextrials sign software agreement

FierceBiotech Research
Umbilical cord stem cells may restore infants' hearing

Obama seeks $156M to boost Alzheimer's research through 2013

Can't get enough donuts A specific gene variation may explain why

Time for a walnut, grape seed, fruit, vegetable and fish oil sandwich

CA stem cell researchers planning for life without state funding

FiercePharma
After dropping ISTA, Valeant nabs another eye-drug company

German data provider accused of selling private script info

Ben Venue's idled plant triggers 'dire' leukemia-drug shortage

WellPoint to drop branded Lipitor from its formulary

Psychologists petition against DSM-5 revisions

FiercePharma Manufacturing
Projects in India, Belgium expand OmniChem's API capacities

Another generic settlement: Janssen, Watson agree on birth control pill

ViroPharma responding quickly to FDA delay of Cinryze manufacturing expansion

Decision on new GSK plant location to come soon

Ernst & Young nailed for $2 million for accounting on Medicis

FierceVaccines
Novartis' Bexsero successfully protects vast majority of infants

Hints of a heroin vaccine from Mexico

Bacterial cancer vaccines show glimpses of activity

Researchers target vaccines for the First Nation

Merck's RotaTeq not linked with bowel problems

Health News - BizJournals.com
FAU medical school applications double

Wake Forest Baptist exec Lambeth running for statehouse

'Immediate jeopardy' status lifted at High Point Regional

AmerisourceBergen CFO DiCandilo leaves suddenly

Feds reject part of states request for Medicaid change

Health News - CNBC
Regeneron climbs after raising Eylea sales outlook

Private equity firm to buy SeraCare for about $78M

Olympus: no big earnings impact from accounting scandal

Factbox: What to expect in Obama's budget for fiscal 2013

FACTBOX-What to expect in Obama's budget for fiscal 2013

Health News - Fox Business
Employers Grateful for Proposed Tax Breaks, But Still Scared

Employers Grateful for Proposed Tax Breaks, Still Scared

Insmed Shares Drop as FDA Halts Study After Rat Test Results

Week Ahead: A Flood Of 2Q Earnings

Pfizer Drug Raises Heart Attack Risk: Study

Inside Industry - Gen
Karolinska Development Establishes KDev Oncology to Corral Cancer Projects

Valeant Pharmaceuticals to Take Over Eyetech

SeraCare to Be Bought by Linden Capital Partners

New Estimate Sharply Raises Projected Cost of Developing a New Drug

Karolinska Develpment Establishes KDev Oncology to Corral Cancer Projects

Marketwire - Pharma and Biotech
Leading Proteomics Company Transitions to Emerald Bio, Chooses Key Leadership to Address Growing Market Opportunities

Insulet Corporation to Present at the Leerink Swann Global Healthcare Conference

Vante Featuring New "Choice-Focused" Line Up of Cutting Edge Catheter Manufacturing Equipment and Services at MD&M West February 14, 15 & 16

Precision Coating Partners With Medi-Solve Coatings, LLC

Top 10 Global Pharmaceutical Manufacturer Sets New Standard for Product Integrity With NanoGuardian

MassBio News
STEM Update from the White House: Engage to Excel: Producing One Million Additional College Graduates with STEM Degrees

MassBio Leading Edge Award Nominations due February 24th

Four New Entrepreneurs Selected for MassCONNECT Mentoring

NUCLEA BIOTECHNOLOGIES ANNOUNCES $3.4 MILLION IN CAPITAL COMMITMENTS

Annual Policy Breakfast Makes Headlines on Healthcare Reform

Medical Pharma - PR Newswire
Cycle for Survival Raises $7.7 million for Rare Cancer Research

Heart to Heart Launches Virtual Blood Donation Campaign to Help Save Israeli Lives

William G. Bithoney, MD, Joins the Healthcare Business of Thomson Reuters

WestPark Capital, Inc. Announces Additional Closing of a $1,100,000 Arrogene NanoTechnology, Inc. Offering

Keystone Dental Launches New Website, www.keystonedental.com

National Center for Biotechnology Information
GEO Series Releases

ClinVar News and Announcements

Behind The Headlines - Health News from NHS Choices

PubMed Health Featured Reviews

SRA News

Nature Biotechnology
OpenVigilfree eyeballs on AERS pharmacovigilance data

The blinded buyer

Planning for the exit

PRIDE Inspector: a tool to visualize and validate MS proteomics data

2011Big biotechs gorge on debt

New York Times- Biotechnology
Cancer Center, in Suit, Claims Ex-Official Took Research

Life Sciences Development Rebounds in Central New Jersey

Amgen and Watson to Work Together on Generic Drugs

A Genome Deluge

Drew Endy: Better Computing for the Things We Care About Most

New York Times- Pharmaceuticals
Twin Births in the U.S., Like Never Before

Joint Effort Announced Against Tropical Diseases

Supply of Methotrexate, a Cancer Drug, May Run Out Soon

Killer Meds, Warring Feds

Exemestane, Thought to Prevent Cancer, Also Causes Bone Loss

OnBioVC
Radius Health, Inc.: Series C $21.4M

Selecta Biosciences, Inc.: Series D $22M

Bind Biosciences, Inc.: Series D $25.5M

NxThera, Inc.: Series B $9M

Hookipa Biotech, GmbH: Series A $9.7M

Outsourcing-Pharma
An experienced CMO is key to successful biologics development says Cobra Biologics

Parexel discusses transdermal drug delivery techs

Sponsors and CROs differ on perception of service quality, says the Avoca Group

Recipharm CEO talks CMO sector recovery and Asian plans

Covance adding mass spec for biosimilars

Pharma News - Business Wire
CORRECTING and REPLACING: Biotage AB (publ) Disclosure Notice of Substantial Holding of Shares

MaxCyte Highlights Gram-Scale Antibody & Protein Production from Transient Transfection of CHO Cells and MaxCyte® VLX Large Scale Transfection System Launch

Salix Pharmaceuticals Announces 4Q2011 and FY2011 Financial Results Conference Call and Webcast

Ironwood Pharmaceuticals Announces Exercise of Over-Allotment Option in Public Offering of Common Stock

Quintiles lance de nouveaux moyens pour permettre le succès des sociétés biopharmaceutiques en Asie

Pharma News - PharmiWeb
Intermountain Healthcare and Cayman Islands Health Services Authority Executives to Present on Revenue Integrity at HIMSS12

Jacobs Project Selected by ENR as "Best of the Best" in 2011

Revised: Catholic Charities USA President Responds to the Administration's Announcement on Religious Liberty

A.T. Still University of Health Sciences Names Craig Phelps President

Bedsider.org Embraces Awkward Sex Moments With New Confessions App On Facebook

Pharma News - PR Newswire
Endo Pharmaceuticals to Present at Citi 2012 Global Health Care Conference

More Than 50 Employers From Across the Nation Tell FTC Mega-PBM Merger Could Increase Costs, Hurt Community Pharmacies

CESAR and Saladax Biomedical Collaborate on a Study of Optimized 5-FU Dosing in Colorectal Cancer Patients

Delcath Appoints Industry Veteran Chris Houchins as Senior Vice President of Clinical and Medical Affairs

Medical Physics Pick: Paper Shows Elekta's Monaco Enables VMAT Delivery of SBRT Without Sacrificing Plan Quality

Pharmaceutical - Moreover
: Pharmaceuticals look to cure pipeline concerns

Drug firms sign up to new tropical disease fight

Cannabis Science Presents Newest Photographs From 3rd Cancer Patient That Show Cancer Tumors Dying and Areas That Are No

Micro Labs attracts private equity and pharma interest: VCCircle

Novartis net dips by 5.3% to Rs.38 crore in Q3

PR Leap - Biotech
Abcam Biochemicals is launched; the new name for Ascent Scientific products

AL-TAR Services, Inc. Adds Thermo-Scientific Product Line to its Online Lab Equipment Store

Ascent Scientific Launch Novel Dynamin Inhibitor Dyngo-4a™ with Children's Medical Research Institute and University of Newcastle

AL-TAR Services, Inc. Names Robert Nugent Director of Business Development

Ascent Scientific licenses novel clathrin inhibitors from Freie Universität Berlin, University of Newcastle and Children's Medical Research Institute

PRWeb - Biotechnology
Wind Energy Update: OEMs Keen to Secure Partnerships as PTC Fears...

Wind Energy Update: Europe's Leading Offshore Wind Supply Chain...

Vergence Labs Smart Eyeglasses Display Facebook and Google into the...

Noble Biomaterials Raises $8 million in Series B Equity Financing

PetroAlgae Changes Name to Parabel

PRWeb - Pharmaceuticals
Winner of CDMA's Product Showcase at the 86th Annual Trade Expo

Data Masons EDI Experts Participating in Microsoft Dynamics AX 2012...

Alandra Medical: One Stop Shop for Medical Device Design, Development...

Safe Opiate Detox & Recovery From Opiates Including Oxycontin...

Baltimore Drug Injury Lawyer Named To Maryland Top 100 List by Super...

Scientific American
In the Andes, Extreme Cold Extracts Bitter Toll

Red Sea: Sounding Radar Buoys Evidence Mars Once Had an Ocean

Senators Consider Banning Automatic Media Sharing on Facebook

Is Cadmium as Dangerous for Children as Lead

Nuclear Reactor Approved in U.S. for First Time Since 1978

Sports - ESPN Basketball
Michigan maintains unblemished home record

Hoyas put away St. John's late from long range

Saint Mary's rebounds with win vs. Santa Clara

Canaan helps Murray St. rebound from 1st loss

Kentucky holds off Vandy, stays perfect in SEC

Sports News - ESPN
Judge sides with Sandusky on grandkids, jury

UConn hires Warde Manuel as athletic director

Diggs, No. 13 prospect, commits to Terrapins

'Foundation set': Notre Dame unveils new staff

Ex-Pitt coach Haywood has charges dropped

Xconomy Life Sciences
Option to Buy: The New Face of Biotech Funding

Synchroneuron, Radius, Acetylon, & More Boston Life Sciences News

SD Life Sciences Roundup: Illumina, Applied Proteomics, & Tocagen

Persistence Pays Off for Synchroneuron Founder

Persistence Pays Off for Synchroneuron Founder With $6M Series A

Yahoo Biotech News
Two Genes for Sealing In Memories Identified (LiveScience.com)

Origin expects to grow China's first GMO corn in 2013 (Reuters)

FDA sets draft rules for biotech drug copies (Reuters)

4 New Genes Linked to Type 2 Diabetes (HealthDay)

More Success With Gene Therapy for Blindness (HealthDay)